Edgewise Announces Positive Long-Term Sevasemten Data Demonstrating Sustained Functional Stabilization in Becker Muscular Dystrophy Through 3.5 Years of Follow-Up

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today presented at the 2026 ...

Why Edgewise Therapeutics (EWTX) Is Up 6.4% After Long-Term Sevasemten Becker Data - And What's Next

Edgewise Therapeutics recently presented long-term data from its MESA open-label extension study of investigational drug ...

Becker’s Healthcare Deploys AI-Driven Infrastructure to Transform Internal Data Operations

CHICAGO, IL, UNITED STATES, March 13, 2026 /EINPresswire.com/ -- Becker’s Healthcare has introduced a new AI-driven ...
The Business Journals

Amazon pulls back on Becker data center plan

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Amazon is the second big tech ...